✦ LIBER ✦

Phase I evaluation of the combination 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and dianhydrogalactitol (DAG; NSC-132313) in patients with advanced neoplastic diseases

✍ Scribed by Creagan, Edward T. ;Eagan, Robert T. ;Rubin, Joseph

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 127 KB
Volume: 7
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950070212

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amphotericin B plus 1,3-BIS (2-chloroeth

Amphotericin B plus 1,3-BIS (2-chloroethyl)-1-nitrosourea (BCNU-NSC NO. 409962) in advanced cancer. Phase I and preliminary phase II results

✍ Cary A. Presant; Carol Klahr; Jitka Olander; Diane Gatewood 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB 👁 1 views

Phase II study of 1,3-Bis (2-chloroethyl

Phase II study of 1,3-Bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC #409962) with amphotericin B in bronchogenic carcinoma

✍ Cary A. Presant; Stephen Hillinger; Carol Klahr 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 1 views

Eighteen patients with unresectable bronchogenic carcinoma were treated with amphotericin B (7.5 mgim' on day I , I5 mg/m2 on day 2, and 30 mg/m2 on days 3 and 4) plus BCNU (250 mg/m2 on day 4 following amphotericin B) with courses of therapy repeated every 8 weeks. All patients had metastatic disea